El interés público prevalece: las resoluciones de precio y reembolso de medicamentos son confidenciales

This article analyzes the latest rulings by the Contentious-Administrative Chamber of the National High Court regarding the confidentiality of pricing & reimbursement decisions for two medicinal products.  Specifically the reasoning judgments to conclude that these documents must remain confidential and cannot be accessed through Law 19/2013 of December 9, on Transparency, Access to Public Information, and Good Governance are analyzed.